{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:42:40Z","timestamp":1782996160142,"version":"3.54.5"},"reference-count":110,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>Hepatitis E virus (HEV), a single-stranded RNA virus, is a leading cause of acute viral hepatitis globally. In recent years, the incidence of hepatitis E has increased significantly, making it a major public health concern globally. Solid organ transplant (SOT) recipients, who require long-term immunosuppressive therapy to prevent graft rejection, are particularly vulnerable to HEV infection because of their immunocompromised state. This population faces a heightened risk of developing chronic hepatitis E, which can progress to liver fibrosis and cirrhosis. Therefore, it is crucial to prioritize the monitoring of SOT recipients in clinical practice, to elucidate the associated risk factors further, and implement stringent diagnostic and preventive measures. Building on previous research, this paper comprehensively reviews the virological characteristics of HEV and the epidemiological features, clinical manifestations, diagnostic approaches, and therapeutic strategies for HEV infection in SOT recipients. The aim of this study is to provide valuable insights for effectively managing, treating, and preventing HEV infection in this high-risk population.<\/jats:p>","DOI":"10.1097\/js9.0000000000002860","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T15:00:10Z","timestamp":1753196410000},"page":"7114-7124","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["When HEV infection meets organ transplantation"],"prefix":"10.1097","volume":"111","author":[{"given":"Changyi","family":"Ji","sequence":"first","affiliation":[{"name":"Anhui Province Key Laboratory of Immunology in Chronic Diseases, Research Center of Laboratory, School of Laboratory, Bengbu Medical University, Bengbu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cunquan","family":"Xiong","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Jiangsu Vocational College Medicine, Yancheng, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Anhui Province Key Laboratory of Immunology in Chronic Diseases, Research Center of Laboratory, School of Laboratory, Bengbu Medical University, Bengbu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Wang","sequence":"additional","affiliation":[{"name":"Anhui Province Key Laboratory of Immunology in Chronic Diseases, Research Center of Laboratory, School of Laboratory, Bengbu Medical University, Bengbu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, China"},{"name":"Suzhou Key Laboratory of Intelligent Critical Illness Biomarkers Translational Research, Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, China"},{"name":"Suzhou Key Laboratory of Intelligent Critical Illness Biomarkers Translational Research, Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, China"},{"name":"Suzhou Key Laboratory of Intelligent Critical Illness Biomarkers Translational Research, Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"e28425","DOI":"10.1002\/jmv.28425","article-title":"Serum extracellular vesicle-derived ASS1 is a promising predictor for the occurrence of HEV-ALF","volume":"95","author":"Xiang","year":"2023","journal-title":"J Med Virol"},{"key":"R2-20260109","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/v15010078","article-title":"Prevalence of Hepatitis E Virus (HEV) in feral and farmed wild boars in Xinjiang, Northwest China","volume":"15","author":"Wu","year":"2022","journal-title":"Viruses"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"1329\u201342","DOI":"10.1111\/liv.15883","article-title":"Global burden of acute hepatitis E between 1990 and 2019 and projections until 2030","volume":"44","author":"Ouyang","year":"2024","journal-title":"Liver Int"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3390\/v15020484","article-title":"Hepatitis E Virus (HEV) in Makkah, Saudi Arabia: a population-based seroprevalence study","volume":"15","author":"El-Daly","year":"2023","journal-title":"Viruses"},{"key":"R5-20260109","doi-asserted-by":"crossref","first-page":"2477\u201388","DOI":"10.1016\/S0140-6736(11)61849-7","article-title":"Hepatitis E","volume":"379","author":"Kamar","year":"2012","journal-title":"Lancet"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"1021\u201340","DOI":"10.2147\/IDR.S449221","article-title":"Hepatitis E Virus (HEV) infection among immunocompromised individuals: a brief narrative review","volume":"17","author":"Alexandrova","year":"2024","journal-title":"Infect Drug Resist"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"1256\u201371","DOI":"10.1016\/j.jhep.2018.03.005","article-title":"EASL clinical practice guidelines on hepatitis E virus infection","volume":"68","author":"Dalton","year":"2018","journal-title":"J Hepatol"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"1109\u201323","DOI":"10.1016\/j.jhep.2022.05.006","article-title":"Chronic hepatitis E: advancing research and patient care","volume":"77","author":"Ma","year":"2022","journal-title":"J Hepatol"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12917-020-02315-5","article-title":"Hepatitis E genotype 3 virus isolate from wild boar is capable of replication in non-human primate and swine kidney cells and mouse neuroblastoma cells","volume":"16","author":"Grigas","year":"2020","journal-title":"BMC Vet Res"},{"key":"R10-20260109","doi-asserted-by":"crossref","first-page":"145\u201354","DOI":"10.1002\/rmv.384","article-title":"Hepatitis E virus","volume":"13","author":"Emerson","year":"2003","journal-title":"Rev Med Virol"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"2223\u201332","DOI":"10.1099\/vir.0.068429-0","article-title":"Consensus proposals for classification of the family hepeviridae","volume":"95","author":"Smith","year":"2014","journal-title":"J Gen Virol"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"298\u2013305","DOI":"10.1016\/j.jinf.2021.07.021","article-title":"Extrahepatic manifestations related to hepatitis E virus infection and their triggering mechanisms","volume":"83","author":"Wu","year":"2021","journal-title":"J Infect"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.3390\/ani13182942","article-title":"Hepatitis e virus (HEV) in heavy pigs in slaughterhouses of Northern Italy: investigation of seroprevalence, viraemia, and faecal shedding","volume":"13","author":"Monini","year":"2023","journal-title":"Animals (Basel)"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"2219\u201321","DOI":"10.3201\/eid2212.160979","article-title":"New hepatitis e virus genotype in Bactrian camels, Xinjiang, China, 2013","volume":"22","author":"Woo","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"811\u201317","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N Engl J Med"},{"key":"R16-20260109","doi-asserted-by":"crossref","first-page":"17086","DOI":"10.1038\/nrdp.2017.86","article-title":"Hepatitis E virus infection","volume":"3","author":"Kamar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R18-20260109","doi-asserted-by":"crossref","first-page":"1516\u201328","DOI":"10.1111\/liv.14468","article-title":"The global epidemiology of hepatitis E virus infection: a systematic review and meta-analysis","volume":"40","author":"Li","year":"2020","journal-title":"Liver Int"},{"key":"R19-20260109","doi-asserted-by":"crossref","first-page":"698\u2013709","DOI":"10.1016\/S1473-3099(08)70255-X","article-title":"Hepatitis E: an emerging infection in developed countries","volume":"8","author":"Dalton","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R20-20260109","doi-asserted-by":"crossref","first-page":"348\u201349","DOI":"10.1016\/j.jchf.2017.12.015","article-title":"Solid organ transplantation","volume":"6","author":"Weinrauch","year":"2018","journal-title":"JACC Heart Fail"},{"key":"R21-20260109","doi-asserted-by":"crossref","first-page":"1143\u201357","DOI":"10.1016\/j.idc.2019.05.008","article-title":"Opportunistic infections in transplant patients","volume":"33","author":"Kumar","year":"2019","journal-title":"Infect Dis Clin North Am"},{"key":"R22-20260109","doi-asserted-by":"crossref","first-page":"1481\u201389","DOI":"10.1053\/j.gastro.2011.02.050","article-title":"Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants","volume":"140","author":"Kamar","year":"2011","journal-title":"Gastroenterology"},{"key":"R23-20260109","doi-asserted-by":"crossref","first-page":"1240\u201354","DOI":"10.3748\/wjg.v27.i12.1240","article-title":"Hepatitis E in solid organ transplant recipients: a systematic review and meta-analysis","volume":"27","author":"Hansrivijit","year":"2021","journal-title":"World J Gastroenterol"},{"key":"R24-20260109","doi-asserted-by":"crossref","first-page":"30\u201337","DOI":"10.3201\/eid1701.100527","article-title":"Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France","volume":"17","author":"Legrand-Abravanel","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"R25-20260109","doi-asserted-by":"crossref","first-page":"3128\u201333","DOI":"10.1111\/j.1600-6143.2012.04200.x","article-title":"Chronic hepatitis e in heart transplant recipients","volume":"12","author":"Pischke","year":"2012","journal-title":"Am J Transplant"},{"key":"R26-20260109","doi-asserted-by":"crossref","first-page":"341\u201346","DOI":"10.1016\/j.healun.2012.11.027","article-title":"Chronic hepatitis E infection in lung transplant recipients","volume":"32","author":"Riezebos-Brilman","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R27-20260109","doi-asserted-by":"crossref","first-page":"1900\u201306","DOI":"10.1093\/infdis\/jiu032","article-title":"Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve into chronic infections","volume":"209","author":"Abravanel","year":"2014","journal-title":"J Infect Dis"},{"key":"R28-20260109","doi-asserted-by":"crossref","first-page":"e29939","DOI":"10.1002\/jmv.29939","article-title":"Incidence and risk factors of de novo hepatitis E virus infection after receiving liver transplantation","volume":"96","author":"He","year":"2024","journal-title":"J Med Virol"},{"key":"R29-20260109","first-page":"874a","article-title":"Longitudinal analysis of hepatitis E virus (HEV) in US cohort of HIV-infected liver and kidney transplant recipients","volume":"66","author":"Sherman","year":"2017","journal-title":"Hepatology"},{"key":"R30-20260109","doi-asserted-by":"crossref","first-page":"1737\u201341","DOI":"10.1016\/j.transproceed.2022.04.025","article-title":"Hepatitis E diagnosis and management after liver, kidney, or heart transplant: a single-center experience","volume":"54","author":"Carter","year":"2022","journal-title":"Transplant Proc"},{"key":"R31-20260109","doi-asserted-by":"crossref","first-page":"1619\u201321","DOI":"10.1017\/S0950268818001887","article-title":"Prevalence of hepatitis E in liver transplant recipients in Greece","volume":"146","author":"Sinakos","year":"2018","journal-title":"Epidemiol Infect"},{"key":"R32-20260109","doi-asserted-by":"crossref","first-page":"e20190302","DOI":"10.1590\/0037-8682-0302-2019","article-title":"Hepatitis E seroprevalence and associated risk factors in croatian liver transplant recipients","volume":"52","author":"Mrzljak","year":"2019","journal-title":"Rev Soc Bras Med Trop"},{"key":"R33-20260109","doi-asserted-by":"crossref","first-page":"926\u201331","DOI":"10.1016\/j.transproceed.2020.01.011","article-title":"Hepatitis E is a rare finding in liver transplant patients with chronic elevated liver enzymes and biopsy-proven acute rejection","volume":"52","author":"Darstein","year":"2020","journal-title":"Transplant Proc"},{"key":"R34-20260109","doi-asserted-by":"crossref","first-page":"20\u201322","DOI":"10.23736\/S0031-0808.20.03877-X","article-title":"Seroprevalence of hepatitis E virus in liver transplant patients in Turin, Italy","volume":"65","author":"Zanotto","year":"2023","journal-title":"Panminerva Med"},{"key":"R35-20260109","doi-asserted-by":"crossref","first-page":"7352","DOI":"10.1038\/s41598-020-64551-x","article-title":"Clinical significance of post-liver transplant hepatitis E seropositivity in high prevalence area of hepatitis E genotype 3: a prospective study","volume":"10","author":"Komolmit","year":"2020","journal-title":"Sci Rep"},{"key":"R36-20260109","first-page":"7\u201311","article-title":"Hepatitis E virus IgG seroprevalence in liver transplant patients: a retrospective single-center experience","volume":"2","author":"Celik","year":"2021","journal-title":"Hepatol Forum"},{"key":"R37-20260109","doi-asserted-by":"crossref","first-page":"68\u201373","DOI":"10.5152\/tjg.2021.21071","article-title":"Hepatitis E infection in solid organ transplant recipients in Turkey","volume":"33","author":"\u00d6\u011f\u00fct","year":"2022","journal-title":"Turk J Gastroenterol"},{"key":"R38-20260109","doi-asserted-by":"crossref","first-page":"e14642","DOI":"10.1111\/petr.14642","article-title":"Prevalence and the impact of hepatitis E infection in pediatric liver transplanted recipients with hepatitis in Thailand","volume":"28","author":"Sintusek","year":"2024","journal-title":"Pediatr Transplant"},{"key":"R39-20260109","doi-asserted-by":"crossref","first-page":"1523\u201330","DOI":"10.1128\/JCM.03624-14","article-title":"Systematic serological testing for hepatitis E virus in kidney transplant recipients","volume":"53","author":"Moal","year":"2015","journal-title":"J Clin Microbiol"},{"key":"R40-20260109","doi-asserted-by":"crossref","first-page":"22\u201326","DOI":"10.34172\/aim.2021.04","article-title":"Hepatitis E virus seroprevalence among liver transplant recipients with persistent elevation of liver enzymes: a single center report","volume":"24","author":"Chorami","year":"2021","journal-title":"Arch Iran Med"},{"key":"R41-20260109","doi-asserted-by":"crossref","first-page":"3266\u201373","DOI":"10.3748\/wjg.v21.i11.3266","article-title":"Hepatitis E in hemodialysis and kidney transplant patients in south-east Italy","volume":"21","author":"Scotto","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R42-20260109","doi-asserted-by":"crossref","first-page":"S757","DOI":"10.1016\/S0168-8278(18)31782-3","article-title":"Incidence of hepatitis E infection in renal transplant patients in the Netherlands","volume":"68","author":"Erken","year":"2018","journal-title":"J Hepatol"},{"key":"R43-20260109","doi-asserted-by":"crossref","first-page":"1215\u201325","DOI":"10.1007\/s00467-018-3905-7","article-title":"Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients","volume":"33","author":"Cordts","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"R44-20260109","doi-asserted-by":"crossref","first-page":"e13033","DOI":"10.1111\/tid.13033","article-title":"Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: a single-center experience in Japan","volume":"21","author":"Nanmoku","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"R45-20260109","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3390\/pathogens12060850","article-title":"Risk factors for hepatitis e virus infection and eating habits in kidney transplant recipients","volume":"12","author":"Wu","year":"2023","journal-title":"Pathogens"},{"key":"R46-20260109","doi-asserted-by":"crossref","first-page":"437\u201344","DOI":"10.1097\/TP.0000000000002801","article-title":"A nationwide survey of hepatitis e virus infection and chronic hepatitis in heart and kidney transplant recipients in Japan","volume":"104","author":"Owada","year":"2020","journal-title":"Transplant"},{"key":"R47-20260109","doi-asserted-by":"crossref","first-page":"fmad011","DOI":"10.1093\/tropej\/fmad011","article-title":"Seroprevalence of hepatitis E virus after pediatric liver transplantation","volume":"69","author":"Getsuwan","year":"2023","journal-title":"J Trop Pediatr"},{"key":"R48-20260109","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13256-015-0655-z","article-title":"Chronic hepatitis E infection with an emerging virus strain in a heart transplant recipient successfully treated with ribavirin: a case report","volume":"9","author":"Waldenstr\u00f6m","year":"2015","journal-title":"J Med Case Rep"},{"key":"R49-20260109","doi-asserted-by":"crossref","first-page":"108\u201311","DOI":"10.1016\/j.clinre.2018.09.010","article-title":"Hepatitis E virus infection in heart transplant recipients, Southeastern France","volume":"43","author":"Luciani","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R50-20260109","doi-asserted-by":"crossref","first-page":"1972\u201376","DOI":"10.1016\/j.transproceed.2015.04.092","article-title":"Incidence of hepatitis e antibodies in swedish lung transplant recipients","volume":"47","author":"Magnusson","year":"2015","journal-title":"Transplant Proc"},{"key":"R51-20260109","doi-asserted-by":"crossref","first-page":"376\u201379","DOI":"10.1016\/j.transproceed.2018.10.006","article-title":"Hepatitis E virus infection in lung transplant recipients: a case series","volume":"51","author":"Ambrocio","year":"2019","journal-title":"Transplant Proc"},{"key":"R52-20260109","doi-asserted-by":"crossref","first-page":"458\u201365","DOI":"10.1111\/jgh.14405","article-title":"Evaluation of an antigen assay for diagnosing acute and chronic hepatitis E genotype 4 infection","volume":"34","author":"Zhang","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"R53-20260109","doi-asserted-by":"crossref","first-page":"467\u201372","DOI":"10.1111\/liv.13037","article-title":"Extrahepatic manifestations of hepatitis E virus","volume":"36","author":"Kamar","year":"2016","journal-title":"Liver Int"},{"key":"R54-20260109","doi-asserted-by":"crossref","first-page":"220\u201326","DOI":"10.1016\/j.jinf.2018.06.007","article-title":"Acute hepatitis E in French patients and neurological manifestations","volume":"77","author":"Abravanel","year":"2018","journal-title":"J Infect"},{"key":"R55-20260109","doi-asserted-by":"crossref","first-page":"498\u2013503","DOI":"10.1212\/WNL.0000000000000112","article-title":"Neuralgic amyotrophy and hepatitis E virus infection","volume":"82","author":"van Eijk","year":"2014","journal-title":"Neurology"},{"key":"R56-20260109","doi-asserted-by":"crossref","first-page":"547\u201353","DOI":"10.1002\/lt.21480","article-title":"Chronic hepatitis E virus infection in liver transplant recipients","volume":"14","author":"Haagsma","year":"2008","journal-title":"Liver Transpl"},{"key":"R57-20260109","doi-asserted-by":"crossref","first-page":"74\u201382","DOI":"10.1002\/lt.21958","article-title":"Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients","volume":"16","author":"Pischke","year":"2010","journal-title":"Liver Transpl"},{"key":"R58-20260109","doi-asserted-by":"crossref","first-page":"597\u2013603","DOI":"10.1136\/gutjnl-2011-300708","article-title":"Chronic hepatitis E infection in children with liver transplantation","volume":"61","author":"Halac","year":"2012","journal-title":"Gut"},{"key":"R59-20260109","doi-asserted-by":"crossref","first-page":"1321\u201324","DOI":"10.1111\/j.1600-6143.2010.03068.x","article-title":"Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis","volume":"10","author":"Kamar","year":"2010","journal-title":"Am J Transplant"},{"key":"R60-20260109","doi-asserted-by":"crossref","first-page":"50\u201358","DOI":"10.1002\/(SICI)1096-9071(199609)50:1<50::AID-JMV10>3.0.CO;2-1","article-title":"IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein","volume":"50","author":"Favorov","year":"1996","journal-title":"J Med Virol"},{"key":"R61-20260109","first-page":"199\u2013213","article-title":"Laboratory diagnosis of HEV infection","volume":"1417","author":"Zhao","year":"2023","journal-title":"Adv Exp Med Biol"},{"key":"R62-20260109","doi-asserted-by":"crossref","first-page":"1081\u201382","DOI":"10.1016\/S0140-6736(00)02737-9","article-title":"Duration of viraemia and faecal viral excretion in acute hepatitis E","volume":"356","author":"Aggarwal","year":"2000","journal-title":"Lancet"},{"key":"R63-20260109","doi-asserted-by":"crossref","first-page":"68\u201369","DOI":"10.1016\/S0140-6736(05)71568-3","article-title":"Viraemia and faecal shedding of HEV in symptom-free carriers","volume":"357","author":"Nicand","year":"2001","journal-title":"Lancet"},{"key":"R64-20260109","doi-asserted-by":"crossref","first-page":"49\u201356","DOI":"10.1128\/JCM.43.1.49-56.2005","article-title":"Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection","volume":"43","author":"Takahashi","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R65-20260109","doi-asserted-by":"crossref","first-page":"e13560","DOI":"10.1371\/journal.pone.0013560","article-title":"Profile of acute infectious markers in sporadic hepatitis E","volume":"5","author":"Huang","year":"2010","journal-title":"PLoS One"},{"key":"R66-20260109","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jhep.2022.10.006","article-title":"Corrigendum to \u2018EASL recommendations on treatment of hepatitis C: final update of the series(\u2018) [J Hepatol 73 (2020) 1170-1218]","volume":"78","year":"2023","journal-title":"J Hepatol"},{"key":"R67-20260109","doi-asserted-by":"crossref","first-page":"e0611","DOI":"10.1097\/HC9.0000000000000611","article-title":"Clinical utility of two-step hepatitis E virus IgM antibody testing in a low-prevalence setting: a 10-year retrospective multicenter study","volume":"9","author":"Chiu","year":"2025","journal-title":"Hepatol Commun"},{"key":"R68-20260109","doi-asserted-by":"crossref","first-page":"8585\u201394","DOI":"10.1007\/s00253-017-8526-8","article-title":"Classification of human and zoonotic group hepatitis E virus (HEV) using antigen detection","volume":"101","author":"Wen","year":"2017","journal-title":"Appl Microbiol Biotechnol"},{"key":"R69-20260109","doi-asserted-by":"crossref","first-page":"1722\u201334","DOI":"10.1002\/hep.32745","article-title":"Urine is a viral antigen reservoir in hepatitis E virus infection","volume":"77","author":"Ying","year":"2023","journal-title":"Hepatology"},{"key":"R70-20260109","doi-asserted-by":"crossref","first-page":"7030\u201345","DOI":"10.3748\/wjg.v22.i31.7030","article-title":"Hepatitis E: discovery, global impact, control and cure","volume":"22","author":"Khuroo","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R71-20260109","doi-asserted-by":"crossref","first-page":"1744\u201348","DOI":"10.1111\/j.1600-6143.2008.02286.x","article-title":"Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients","volume":"8","author":"Kamar","year":"2008","journal-title":"Am J Transplant"},{"key":"R72-20260109","doi-asserted-by":"crossref","first-page":"15\u201320","DOI":"10.1097\/TP.0000000000001908","article-title":"Summary of the British Transplantation Society UK guidelines for hepatitis E and solid organ transplantation","volume":"102","author":"McPherson","year":"2018","journal-title":"Transplant"},{"key":"R73-20260109","doi-asserted-by":"crossref","first-page":"1578\u201385","DOI":"10.1111\/j.1600-6143.2006.01360.x","article-title":"Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis","volume":"6","author":"McAlister","year":"2006","journal-title":"Am J Transplant"},{"key":"R74-20260109","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","article-title":"Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data","volume":"331","author":"Webster","year":"2005","journal-title":"Bmj"},{"key":"R75-20260109","doi-asserted-by":"crossref","first-page":"58\u201366","DOI":"10.1016\/j.healun.2008.10.004","article-title":"Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis","volume":"28","author":"Ye","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R76-20260109","doi-asserted-by":"crossref","first-page":"557\u201364","DOI":"10.1016\/j.jhep.2021.04.036","article-title":"Resolution of hepatitis E virus infection in CD8+ T cell-depleted rhesus macaques","volume":"75","author":"Bremer","year":"2021","journal-title":"J Hepatol"},{"key":"R77-20260109","doi-asserted-by":"crossref","first-page":"123\u201346","DOI":"10.1016\/0163-7258(79)90058-5","article-title":"Ribavirin: an antiviral agent","volume":"6","author":"Sidwell","year":"1979","journal-title":"Pharmacol Ther"},{"key":"R78-20260109","doi-asserted-by":"crossref","first-page":"1111\u201320","DOI":"10.1056\/NEJMoa1215246","article-title":"Ribavirin for chronic hepatitis E virus infection in transplant recipients","volume":"370","author":"Kamar","year":"2014","journal-title":"N Engl J Med"},{"key":"R79-20260109","doi-asserted-by":"crossref","first-page":"722\u201326","DOI":"10.1111\/liv.12114","article-title":"Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience","volume":"33","author":"Pischke","year":"2013","journal-title":"Liver Int"},{"key":"R80-20260109","doi-asserted-by":"crossref","first-page":"1204\u201311","DOI":"10.1093\/cid\/ciz953","article-title":"Ribavirin for hepatitis E virus infection after organ transplantation: a large European retrospective multicenter study","volume":"71","author":"Kamar","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R81-20260109","doi-asserted-by":"crossref","first-page":"3351\u201357","DOI":"10.2174\/092986706778773059","article-title":"Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research","volume":"13","author":"Russmann","year":"2006","journal-title":"Curr Med Chem"},{"key":"R82-20260109","doi-asserted-by":"crossref","first-page":"443\u201351","DOI":"10.1053\/jhep.2003.50031","article-title":"Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups","volume":"37","author":"Schaefer","year":"2003","journal-title":"Hepatology"},{"key":"R83-20260109","doi-asserted-by":"crossref","first-page":"176\u201384","DOI":"10.1136\/gutjnl-2020-323569","article-title":"Sofosbuvir\/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"key":"R84-20260109","doi-asserted-by":"crossref","first-page":"551\u201359","DOI":"10.1002\/bdra.20682","article-title":"The ribavirin pregnancy registry: findings after 5 years of enrollment, 2003-2009","volume":"88","author":"Roberts","year":"2010","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R85-20260109","doi-asserted-by":"crossref","first-page":"1008\u201311.e7;quize15\u20136","DOI":"10.1053\/j.gastro.2014.08.040","article-title":"A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients","volume":"147","author":"Debing","year":"2014","journal-title":"Gastroenterology"},{"key":"R86-20260109","doi-asserted-by":"crossref","first-page":"1733\u201343","DOI":"10.1136\/gutjnl-2015-311000","article-title":"In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome","volume":"65","author":"Todt","year":"2016","journal-title":"Gut"},{"key":"R87-20260109","doi-asserted-by":"crossref","first-page":"e0337222","DOI":"10.1128\/mbio.03372-22","article-title":"Ribavirin treatment failure-associated mutation, Y1320H, in the RNA-dependent RNA polymerase of genotype 3 Hepatitis E Virus (HEV) enhances virus replication in a rabbit HEV infection model","volume":"14","author":"Wang","year":"2023","journal-title":"mBio"},{"key":"R88-20260109","doi-asserted-by":"crossref","first-page":"31\u201342","DOI":"10.1016\/j.ebiom.2016.07.039","article-title":"Hepatitis E virus mutations: functional and clinical relevance","volume":"11","author":"van Tong","year":"2016","journal-title":"EBioMedicine"},{"key":"R89-20260109","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1016\/S0168-8278(03)00329-5","article-title":"Treatment of HBeAg-negative chronic hepatitis B with interferon or pegylated interferon","volume":"39 Suppl 1","author":"Brunetto","year":"2003","journal-title":"J Hepatol"},{"key":"R90-20260109","doi-asserted-by":"crossref","first-page":"6627\u201331","DOI":"10.3748\/wjg.14.6627","article-title":"Is pegylated interferon superior to interferon, with ribavarin, in chronic hepatitis C genotypes 2\/3?","volume":"14","author":"Jamall","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R91-20260109","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s12879-020-05212-2","article-title":"Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients","volume":"20","author":"Ollivier-Hourmand","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R92-20260109","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1086\/650488","article-title":"Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation","volume":"50","author":"Kamar","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R93-20260109","doi-asserted-by":"crossref","first-page":"353\u201360","DOI":"10.1097\/TP.0b013e3181c4096c","article-title":"Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation","volume":"89","author":"Kamar","year":"2010","journal-title":"Transplant"},{"key":"R94-20260109","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00705-023-05770-1","article-title":"Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus","volume":"168","author":"Bhise","year":"2023","journal-title":"Arch Virol"},{"key":"R95-20260109","first-page":"269\u201371","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"R96-20260109","first-page":"81\u201385","article-title":"2017 FDA drug approvals","volume":"17","author":"Mullard","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"R97-20260109","doi-asserted-by":"crossref","first-page":"131756","DOI":"10.1016\/j.molstruc.2021.131756","article-title":"RdRp (RNA-dependent RNA polymerase): a key target providing anti-virals for the management of various viral diseases","volume":"1250","author":"Pathania","year":"2022","journal-title":"J Mol Struct"},{"key":"R98-20260109","doi-asserted-by":"crossref","first-page":"41570\u201378","DOI":"10.1021\/acsomega.3c05637","article-title":"Inhibition of HEV replication by FDA-approved RdRp inhibitors","volume":"8","author":"Hooda","year":"2023","journal-title":"ACS Omega"},{"key":"R99-20260109","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JVI.00754-17","article-title":"Zinc salts block hepatitis E virus replication by inhibiting the activity of viral RNA-dependent RNA polymerase","volume":"91","author":"Kaushik","year":"2017","journal-title":"J Virol"},{"key":"R100-20260109","doi-asserted-by":"crossref","first-page":"723\u201330","DOI":"10.1016\/j.jinf.2016.02.016","article-title":"Conventional and innate lymphocytes response at the acute phase of HEV infection in transplanted patients","volume":"72","author":"Abravanel","year":"2016","journal-title":"J Infect"},{"key":"R101-20260109","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3390\/vaccines8030422","article-title":"Hepatitis E virus: how it escapes host innate immunity","volume":"8","author":"Lhomme","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"R102-20260109","doi-asserted-by":"crossref","first-page":"978\u201390","DOI":"10.1016\/j.jhep.2022.05.019","article-title":"Mechanisms of CD8+ T-cell failure in chronic hepatitis E virus infection","volume":"77","author":"Kemming","year":"2022","journal-title":"J Hepatol"},{"key":"R103-20260109","doi-asserted-by":"crossref","first-page":"78\u201389","DOI":"10.1111\/jvh.12156","article-title":"Chronic hepatitis E: a review of the literature","volume":"21","author":"Fujiwara","year":"2014","journal-title":"J Viral Hepat"},{"key":"R104-20260109","doi-asserted-by":"crossref","first-page":"143\u201348","DOI":"10.1080\/14787210.2023.2166932","article-title":"Diagnostic and management strategies for chronic hepatitis E infection","volume":"21","author":"Abravanel","year":"2023","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R105-20260109","doi-asserted-by":"crossref","first-page":"1869\u201374","DOI":"10.1016\/j.vaccine.2008.12.061","article-title":"Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine","volume":"27","author":"Zhang","year":"2009","journal-title":"Vaccine"},{"key":"R106-20260109","doi-asserted-by":"crossref","first-page":"895\u2013902","DOI":"10.1016\/S0140-6736(10)61030-6","article-title":"Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial","volume":"376","author":"Zhu","year":"2010","journal-title":"Lancet"},{"key":"R107-20260109","doi-asserted-by":"crossref","first-page":"813\u201323","DOI":"10.1016\/S0140-6736(23)02234-1","article-title":"Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"403","author":"Huang","year":"2024","journal-title":"Lancet"},{"key":"R108-20260109","doi-asserted-by":"crossref","first-page":"737486","DOI":"10.3389\/fmicb.2021.737486","article-title":"The unmet needs of hepatitis E virus diagnosis in suspected drug-induced liver injury in limited resource setting","volume":"12","author":"El-Mokhtar","year":"2021","journal-title":"Front Microbiol"},{"key":"R109-20260109","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/medicina56050206","article-title":"Implications of hepatitis E virus in blood transfusions, hemodialysis, and solid organ transplants","volume":"56","author":"Janahi","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"R110-20260109","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/microorganisms8010051","article-title":"Ribavirin as a first treatment approach for hepatitis E virus infection in transplant recipient patients","volume":"8","author":"Rivero-Juarez","year":"2019","journal-title":"Microorganisms"},{"key":"R111-20260109","doi-asserted-by":"crossref","first-page":"853\u201359","DOI":"10.1111\/hepr.13354","article-title":"Predictive factors of anemia during sofosbuvir and ribavirin therapy for genotype 2 chronic hepatitis C patients","volume":"49","author":"Urabe","year":"2019","journal-title":"Hepatol Res"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002860","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:01:38Z","timestamp":1767963698000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":110,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000002860","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"2025-02-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}